{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:34:38Z","timestamp":1790634878556,"version":"4.1.0"},"reference-count":53,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1721,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1365-2982.2010.01643.x","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T14:17:32Z","timestamp":1292422652000},"page":"193-200","source":"Crossref","is-referenced-by-count":47,"title":["LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin"],"prefix":"10.1111","volume":"23","author":[{"given":"M.","family":"Camilleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,15]]},"reference":[{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.7326\/0003-4819-73-4-607","article-title":"Serotonin now: clinical implications of inhibiting its synthesis with para-chlorophenylalanine","volume":"73","author":"NEJM","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archpsyc.1976.01770070041003","article-title":"Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients","volume":"33","author":"Shopsin","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.mp.4001949","article-title":"Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies","volume":"12","author":"Ruh\u00e9","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","article-title":"Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue","volume":"315","author":"Kvols","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB5|cit5","first-page":"2250","article-title":"Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome","volume":"92","author":"Saslow","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJM199310073291503","article-title":"Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea","volume":"329","author":"von der Ohe","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB7|cit7","first-page":"E85","article-title":"Effect of serotonin treatment on intestinal transport in the rabbit","volume":"232","author":"Donowitz","year":"1977","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0016-5085(76)80054-6","article-title":"Effect of serotonin on water and electrolyte transport in the in vivo rabbit small intestine","volume":"71","author":"Kisloff","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/gut.42.5.628","article-title":"Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea","volume":"42","author":"Saslow","year":"1998","journal-title":"Gut"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0006-2952(95)02006-X","article-title":"Elevated aromatic-L-amino acid decarboxylase in human carcinoid tumors","volume":"50","author":"Gilbert","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2982.2004.00632.x","article-title":"Editorial: Mechanisms in IBS: something old, something new, something borrowed\u2026","volume":"17","author":"Camilleri","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1542-3565(04)00159-4","article-title":"Infection, immune function, and functional gut disorders","volume":"2","author":"Spiller","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB13|cit13","first-page":"S1","article-title":"An evidence-based systematic review on the management of irritable bowel syndrome","volume":"10","author":"Brandt","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/j.gastro.2008.09.005","article-title":"Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles","volume":"135","author":"Camilleri","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ajg.2010.25","article-title":"Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: clinical characteristics, outcomes, and incidences","volume":"105","author":"Chang","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cgh.2009.10.020","article-title":"Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function","volume":"8","author":"Odunsi-Shiyanbade","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.2009.04153.x","article-title":"New receptor targets for medical therapy in irritable bowel syndrome","volume":"31","author":"Camilleri","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MED.0b013e32831e9c8e","article-title":"Serotonin in the gastrointestinal tract","volume":"16","author":"Camilleri","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obesity"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1111\/j.1572-0241.2000.03177.x","article-title":"Serotonin: a mediator of the brain-gut connection","volume":"95","author":"Kim","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","article-title":"Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome","volume":"3","author":"Dunlop","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/gut.52.5.663","article-title":"Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome","volume":"52","author":"Houghton","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1440-1746.2006.04772.x","article-title":"Plasma and gastric mucosal 5-hydroxytryptamine concentrations following cold water intake in patients with diarrhea-predominant irritable bowel syndrome","volume":"22","author":"Zuo","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome","volume":"130","author":"Atkinson","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.gastro.2010.03.032","article-title":"Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients","volume":"139","author":"Faure","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gut.47.6.804","article-title":"Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome","volume":"47","author":"Spiller","year":"2000","journal-title":"Gut"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000051888","article-title":"Patients with constipation-predominant irritable bowel syndrome (ibs) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits","volume":"63","author":"Miwa","year":"2001","journal-title":"Digestion"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","article-title":"Molecular defects in mucosal serotonin content and decreased serotonin re-uptake transporter in ulcerative colitis and irritable bowel syndrome","volume":"126","author":"Coates","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2982.2008.01100.x","article-title":"Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients","volume":"20","author":"Kerckhoffs","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2006.11.020","article-title":"Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome","volume":"132","author":"Camilleri","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1111\/j.1572-0241.2003.08669.x","article-title":"Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron","volume":"98","author":"Bellini","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1365-2036.2007.03453.x","article-title":"Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome","volume":"26","author":"Van Kerkhoven","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/hmg\/ddn195","article-title":"First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome","volume":"17","author":"Kapeller","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cgh.2007.12.015","article-title":"Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta analysis of randomized controlled trials","volume":"6","author":"Andresen","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000150632","article-title":"A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome","volume":"77","author":"Matsueda","year":"2008","journal-title":"Digestion"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1080\/00365520802240255","article-title":"A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome","volume":"43","author":"Matsueda","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2982.2006.00865.x","article-title":"Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans","volume":"19","author":"Camilleri","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa0800670","article-title":"A placebo-controlled trial of prucalopride for severe chronic constipation","volume":"358","author":"Camilleri","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2982.2009.01378.x","article-title":"Effects of velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation","volume":"22","author":"Manini","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2982.2007.01059.x","article-title":"5-HT4 receptor agonists: similar but not the same","volume":"20","author":"De Maeyer","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.174.4007.428","article-title":"Social behavior of monkeys selectively depleted of monoamines","volume":"174","author":"Redmond","year":"1971","journal-title":"Science"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1021\/jm800338j","article-title":"Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders","volume":"51","author":"Shi","year":"2008","journal-title":"J Med Chem"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1016\/j.bmcl.2009.07.005","article-title":"Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors","volume":"19","author":"Jin","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.107.132670","article-title":"Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit 5-HT synthesis in the gastrointestinal tract","volume":"325","author":"Liu","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB45|cit45","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-200709002-01055","article-title":"From mouse knockout to investigational drug: LX1031, a novel potential treatment for irritable bowel syndrome","volume":"102","author":"Brown","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"Suppl.1","key":"10.1111\/j.1365-2982.2010.01643.x-BIB46|cit46","first-page":"A352","article-title":"LX1032: a potential new therapy for chronic diarrhea in cardinoid syndrome","volume":"136","author":"Pappas","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB47|cit47","article-title":"LX1031: inhibition of 5-HT synthesis as a new target in the management of irritable bowel syndrome (IBS)","volume":"21","author":"Freiman","year":"2009","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl.1","key":"10.1111\/j.1365-2982.2010.01643.x-BIB48|cit48","first-page":"A237","article-title":"LX1031: a new approach for managing irritable bowel syndrome (IBS)","volume":"136","author":"Brown","year":"2009","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2982.2010.01643.x-BIB49|cit49","article-title":"5-HT biomarker levels correlate with clinical response in phase 2 trial of LX1031, a novel 5-HT synthesis inhibitor for non-constipating IBS","volume":"136","author":"Zambrowicz","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ajg.2010.12","article-title":"Evolution of clinical trials for irritable bowel syndrome: issues in end points and study design","volume":"105","author":"Trentacosti","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1113\/jphysiol.2002.025452","article-title":"Excitation of rat colonic afferent fibres by 5-HT(3) receptors","volume":"544","author":"Hicks","year":"2002","journal-title":"J Physiol"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.1365-2036.2002.01287.x","article-title":"The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients","volume":"16","author":"Mayer","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01643.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","article-title":"Pharmacological inhibition of gut-derived 5-HT synthesis is a potential bone anabolic treatment for osteoporosis","volume":"16","author":"Yadav","year":"2010","journal-title":"Nat Med"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2010.01643.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2982.2010.01643.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T01:28:59Z","timestamp":1712021339000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2010.01643.x"}},"subtitle":["LX-1031, potential in IBS-D"],"short-title":[],"issued":{"date-parts":[[2010,12,15]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2010.01643.x","relation":{},"ISSN":["1350-1925"],"issn-type":[{"value":"1350-1925","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,15]]}}}